EUVIMEDEUVIMED entdecken
Open Access

An Immunoinformatic Approach for a Multi‐Epitope Vaccine Against Toxoplasma gondii

Negar Asadi, Leila Navapour, Navid Mogharrab, Elham Yousefi, Sadegh Feizollahzadeh, Mortaza Taheri-Anganeh iD, Shahram Khademvatan, Gordon S Howarth

Parasite Immunology · 2026-07 · 48 (7)

DOI: 10.1111/pim.70095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Parasite Immunology, online erschienen am 22.07.2026. Verfasst von Negar Asadi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran. Hauptthemen laut MEDLINE: Toxoplasma, Protozoan Vaccines, Epitopes, B-Lymphocyte, Antigens, Protozoan. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Research Project of the Cellular and Molecular Research Center of Urmia University of Medical Science, Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection with the intracellular apicomplexan parasite Toxoplasma gondii causes severe and often fatal clinical outcomes worldwide, especially in patients with immunodeficiency, diabetes and in pregnant women and infants. Despite approximately one‐third of the global population being infected with T. gondii , there is currently no effective vaccine available for humans. The objective was to develop a potential vaccine candidate for T. gondii , which would incorporate the B‐ and T‐lymphocyte epitopes derived from three immunogenic antigens of the parasite. Initially, the immunodominant epitopes present in the SAG1, GRA6 and GRA7 proteins of T. gondii were identified. Following this, a multi‐epitope vaccine was developed by integrating B‐cell epitopes, CTL epitopes and HTL epitopes, with the addition of the 50S ribosomal protein L7/L12 serving as an adjuvant to enhance the immunogenic properties of the vaccine. All identified epitopes demonstrated characteristics of being antigenic, nonallergenic, nontoxic and lacking human homologues. Furthermore, the candidate vaccine exhibited immunogenicity, non‐allergenicity and stability. Molecular docking studies indicated robust interactions between the vaccine construct and the TLR‐4 immune receptor. Additionally, the stability of the formulated vaccine was confirmed through molecular dynamic simulations. In silico analyses suggested that the vaccine construct could effectively initiate primary immune responses; however, further laboratory evaluations are required to verify its efficacy and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxoplasmaProtozoan VaccinesEpitopes, B-LymphocyteAntigens, ProtozoanToxoplasmosisEpitopes, T-LymphocyteImmunoinformaticsHumansProtozoan ProteinsMolecular Docking SimulationAnimalsImmunodominant EpitopesProtein Subunit Vaccines

Stichwörter der Autor:innen

Toxoplasma gondiiantigensbioinformaticsmulti‐epitopevaccines

Substanzen

Protozoan VaccinesEpitopes, B-LymphocyteAntigens, ProtozoanEpitopes, T-LymphocyteProtozoan ProteinsImmunodominant EpitopesProtein Subunit VaccinesGRA6 protein, Toxoplasma gondiiGRA7 protein, Toxoplasma gondiiSAG1 antigen, Toxoplasma

Autor:innen und Institutionen

  • Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
  • Biophysics and Computational Biology Laboratory (BCBL), Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran.
  • Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Medical Parasitology and Mycology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Immunology and Genetics, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Veterinary Biosciences, Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Mortaza Taheri-Anganeh

Förderung

  • Research Project of the Cellular and Molecular Research Center of Urmia University of Medical Science, Iran

Zitieren

APA

Asadi, N., Navapour, L., Mogharrab, N., Yousefi, E., Feizollahzadeh, S., Taheri-Anganeh, M., Khademvatan, S., & Howarth, G. S. (2026). An Immunoinformatic Approach for a Multi‐Epitope Vaccine Against Toxoplasma gondii. Parasite Immunology, 48(7). https://doi.org/10.1111/pim.70095

Vancouver

Asadi N, Navapour L, Mogharrab N, Yousefi E, Feizollahzadeh S, Taheri-Anganeh M, et al. An Immunoinformatic Approach for a Multi‐Epitope Vaccine Against Toxoplasma gondii. Parasite Immunology. 2026;48(7). doi:10.1111/pim.70095

BibTeX
@article{Asadi2026,
  author = {Asadi, Negar and Navapour, Leila and Mogharrab, Navid and Yousefi, Elham and Feizollahzadeh, Sadegh and Taheri-Anganeh, Mortaza and Khademvatan, Shahram and Howarth, Gordon S},
  title = {An Immunoinformatic Approach for a Multi‐Epitope Vaccine Against Toxoplasma gondii},
  journal = {Parasite Immunology},
  year = {2026},
  volume = {48},
  number = {7},
  doi = {10.1111/pim.70095}
}
Kostenlos starten →